Jee yun Lee, MD,Ph.D.

Trials

Studies that name Jee yun Lee, MD,Ph.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:13 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT02449655 · Trial of AZD5363 Plus Paclitaxel /AZD2014 Plus Paclitaxel in Biomarker Negative (PIK3CA/MEK/RAS/TP53/MET) Gastric Adenocarcinoma Patients as Second-line Chemotherapy

  Samsung Medical Center · terminated · Advanced Gastric Adenocarcinoma · principal investigator
• Ph2
  NCT02449538 · Study to Evaluate the Safety and Efficacy of Everolimus, in Subjects With PIK3CA Amplification, PTEN Loss and PIK3CA Mutation Refractory Solid Tumors

  Samsung Medical Center · completed · Solid Tumor · principal investigator
• Ph2
  NCT02449551 · Study of AZD6094 (Volitinib) in Advanced Gastric Adenocarcinoma Patients With MET Amplification as a Third-line Treatment

  Samsung Medical Center · completed · Advanced Gastric Adenocarcinoma · principal investigator
• N/A
  NCT02449564 · The Pilot Study Evaluate the Safety and Efficacy of Sirolimus in Patients With PIK3CA Mutation and/or PIK3CA Amplification Refractory Solid Tumors

  Samsung Medical Center · completed · Solid Tumor · principal investigator
• Ph2
  NCT02448329 · Study of AZD1775 in Combination With Paclitaxel, in Advanced Gastric Adenocarcinoma Patients Harboring TP53 Mutation as a Second-line Chemotherapy

  Samsung Medical Center · completed · Advanced Gastric Adenocarcinoma · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 11:13 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.